Journals / Viral Hepatitis Journal / 2017 / Cilt: 23 - Sayı: 2

İki-On Altı Yaş Arası Çocukların Hepatit A Seroprevalansı ve Aşılanma Durumunun Değerlendirilmesi

Evaluation of the Seroprevalence of Hepatit A and Vaccination Status in Children Aged Two and Sixteen Years

Pages
46–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that school age children were unvaccinated, and anti-HAV IgG was positive in 19.6% of the children and negative in 80.4% of the children.Conclusion: In our study, although the prevalence of hepatitis A was found to be low compared to the eastern and southeastern cities of our country, it is still higher than in the developed countries.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study; the aim was to evaluate the seroprevalence of hepatitis A virus (HAV) in 2-16 year age group, and the rate of hepatitis A vaccination.Materials and Methods: This study was conducted on 400 children aged between 2 and 16 years with no chronic diseases who attended the pediatrics outpatient clinic in Health Sciences University, Haydarpaşa Numune Training and Research Hospital.
📊
Key Findings & Data:Results: In this study 44.3% of the participants included were girls and 55.8% were boys.
💡
Conclusion & Impact:It was found that school age children were unvaccinated, and anti-HAV IgG was positive in 19.6% of the children and negative in 80.4% of the children.Conclusion: In our study, although the prevalence of hepatitis A was found to be low compared to the eastern and southeastern cities of our country, it is still higher than in the developed countries.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study; the aim was to evaluate the seroprevalence of hepatitis A virus (HAV) in 2-16 year age group, and the rate of hepatitis A vaccination.Materials and Methods: This study was conducted on 400 children aged between 2 and 16 years with no chronic diseases who attended the pediatrics outpatient clinic in Health Sciences University, Haydarpaşa Numune Training and Research Hospital. After obtaining informed consent from the parents, blood samples were taken for investigating serological markers for hepatitis A in the microbiology laboratory using the ELISA method. The parents were asked whether or not their children had been vaccinated against hepatitis A. Results: In this study 44.3% of the participants included were girls and 55.8% were boys. The mean age of the children was 10.8±4.18 years. 27.3% of patients were anti-HAV IgG-positive, and 11% had been vaccinated against hepatitis A. When we compared preschool and school age patients, anti-HAV IgG positivity was detected in all children who were vaccinated in the preschool group; while 5.9% of unvaccinated children were anti-HAV IgG-positive and 94.1% were negative. It was found that school age children were unvaccinated, and anti-HAV IgG was positive in 19.6% of the children and negative in 80.4% of the children.Conclusion: In our study, although the prevalence of hepatitis A was found to be low compared to the eastern and southeastern cities of our country, it is still higher than in the developed countries. In order to prevent hepatitis A infection, it is necessary to improve the socio-economic conditions of the country, to create better sanitary conditions and hygienic practices, and raise awareness of the infection

Özet

Amaç: Bu çalışmada 2-16 yaş grubu olgularda, hepatit A virüsünün (HAV) seroprevalansının ve hepatit A aşısının yaptırılma oranlarının değerlendirilmesi amaçlandı.Gereç ve Yöntemler: Sağlık Bilimleri Üniversitesi, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Çocuk Polikliniği'ne başvuran 2-16 yaş arası, kronik hastalığı olmayan 400 çocuk araştırma kapsamına alındı. Ailelerin onayı alındıktan sonra alınan kan örneği tıbbi mikrobiyoloji laboratuvarına gönderilip ELISA yöntemi ile hepatit A serolojik belirteçleri çalışıldı. Hastalara, hepatit A aşısını yaptırıp yaptırmadıkları soruldu. Bulgular: Çalışmaya alınan çocukların 177'si (%44,3) kız, 223'ü (%55,8) erkek olup ortalama yaşları 10,8+/-4,18 yıldı. Olguların 109'unun (%27,3) anti-HAV IgG'si pozitifti ve 44'ü (%11) hepatit A aşısı yaptırmıştı. Okul öncesi ve okul dönemi olarak karşılaştırdığımızda okul öncesi grupta aşı olan tüm çocuklarda antiHAV IgG pozitifliği görülürken; aşı olmayan çocukların %5,9'unda anti-HAV IgG pozitif, %94,1'inde negatiftir. Okul dönemindeki çocuklarda aşı varlığı görülmezken, çocukların %19,6'sında anti-HAV IgG pozitif iken, %80,4'ünde negatiftir.Sonuç: Çalışmamızda, hepatit A prevalansı ülkemizin Doğu ve Güneydoğu illerine göre düşük bulunsa da halen gelişmiş ülkelerin seroprevalansına göre yüksek seyretmektedir. Bunu önlemek için ülkenin sosyo-ekonomik şartlarının düzeltilmesi ve toplumun bilinçlendirilmesi gerekmektedir. Sağlık Bakanlığı Ulusal Aşı Programı kapsamındaki hepatit A aşısı ile HAV enfeksiyonu sıklığı azalacaktır

🔖

Cite This Article

KOLANCALI, N., ÖNAL, Z. E., AKSARAY, S., NUHOĞLU, Ç. (2017). İki-On Altı Yaş Arası Çocukların Hepatit A Seroprevalansı ve Aşılanma Durumunun Değerlendirilmesi. Viral Hepatitis Journal, Cilt: 23 - Sayı: 2, 46–49. https://ajindex.com/articles/332675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tosun S, Ayaz H, Deveci S, Aksu S. Çocuk ve erişkinlerde hepatit A virusu ile karşılaşma durumunun değerlendirilmesi. Antalya: X.Ulusal Viral Hepatit Kongre Kitabı; 2010; p. 121
  2. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653- 6657
  3. NadaYazigiand William F. Balistreri: Viralhepatitis. In: Kleigman RM, Behrman RE, Jenson HB, Stanson BF, (eds.), Nelson textbook of Pediatrics 20th Edition; 2015; p. 1680-1690
  4. Badur S. Viral Hepatitler (HAV, HBV, HDV). İçinde: Ustaçelebi Ş, Abacıoğlu H, Badur S, (eds.), Moleküler, Klinik, Tanısal Viroloji. Ankara: Güneş Kitabevi; 2004; p.175-183
  5. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence a global review and analysis. Epidemiol Infect. 2004;132:1005- 1022
  6. Erdoğan MS, Oktun M, Tatman-Otkun M, Akata F, Türe M. The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey. Eur J Epidemiol. 2004;19:267-273
  7. Taşyaran MA, Akdağ R, Akyüz M, Parlak M, Ceviz N, Yılmaz S. Erzurum bölgesi çocuklarında fekal oral bulaşan hepatit viruslarının seroprevalansı. Klinik Dergi. 1994;7:74-75
  8. Shah U, Habib Z, Kleinman RE. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics. 2000;105:436- 438
  9. Malay S, Tizer K, Lutwick LI. Current Update of Pediatric Hepatitis Vaccine Use. Pediatr Clin North Am. 2000;47:395-406
  10. Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, Qorbani M, Heshmat R, Tajadini MH, Ghaffari Hoseini S. Comparison of the prevalence and risk factors of hepatitis A in 10 to 18-year-old adolescents of sixteen IranianProvinces: The CASPIAN-III Study. Hepat Mon. 2016;16:e36437
  11. Stephen MF, Ian DG. Hepatitis A Virus. In: Mandell GL, Bennett JE, Dolin R, (eds.), Principles and Practice of Infectious Disease. Churchill Livingstones: Newyork: 2000;p. 1920-1940
  12. Yapicioglu H, Alhan E, Yildizdas D, Yaman A, Bozdemir N. Prevalence of hepatitis A in children and adolescents in Adana, Turkey. Indian Pediatr. 2002;39:936-941
  13. Atabek ME, Fındık D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti- HEV antibodies in Konya, Turkey. Health Policy. 2004;67:265- 269
  14. Karaman S, Karaman K, Kızılyıldız BS, Ceylan N, Kaba S, Parlak M, Beger B, Ceylan A. Seroprevalance of hepatitis a and associated factors among 1-15 year old children in Eastern Turkey. Int J Clin Exp. 2015;8:19394-19399. 15. http://www.medikalakademi.com.tr/hepatit-a-asisi-sayesin